Product Information
MECLIZINE 12.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0442 per EA under NDC 59651080701. Its NADAC has been published 122 times since Jun 5, 2024.
FDA first approved this application on Sep 17, 2012. Its Orange Book therapeutic-equivalence code is AA.
Strength
12.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651080701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202640FDA Approved
9/17/2012
TE Code
AA
On Market Since
9/14/2023
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 12.5 MG TABLET has been published 122 times since Jun 5, 2024, and over the history we have for it it has declined 10.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0442 per EA |
|---|---|
| All-time high | $0.0638 (Jul 10, 2024) |
| All-time low | $0.0418 (Nov 20, 2024) |
| 52-week high | $0.0497 |
| 52-week low | $0.0442 |
| Median price | $0.0494 |
| Average price | $0.0506 |
| Largest weekly change | -29.2% (Nov 20, 2024) |
| Weeks tracked | 122 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MECLIZINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MECLIZINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiemetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MECLIZINE 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 12.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0442 per EA (NDC 59651080701), effective Sep 30, 2026.
How has the price of MECLIZINE 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 12.5 MG TABLET has declined 10.7%. It has been tracked across 122 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for MECLIZINE 12.5 MG TABLET?
Since Jun 5, 2024, the NADAC for MECLIZINE 12.5 MG TABLET has ranged from a low of $0.0418 (Nov 20, 2024) to a high of $0.0638 (Jul 10, 2024), with a median of $0.0494 per EA.
Are there cheaper alternatives to MECLIZINE 12.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MECLIZINE 12.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MECLIZINE 12.5 MG TABLET?
MECLIZINE 12.5 MG TABLET (NDC 59651080701) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.